Literature DB >> 2509268

Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats.

C Löser1, U R Fölsch, U Cleffmann, R Nustede, W Creutzfeldt.   

Abstract

This study was designed to investigate changes of ornithine decarboxylase and polyamines during pancreatic adaptation in response to feeding of the synthetic protease inhibitor camostate. alpha-Difluoromethylornithine, an irreversible and specific inhibitor of ornithine decarboxylase, was applied simultaneously to elucidate the essential role of polyamines in pancreatic growth. Cholecystokinin (CCK) plasma levels in camostate-fed rats increased from basal values of 3-4 pmol/l to a maximal level of 27.4 pmol/l after 2h; they then decreased up to 12 h but remained elevated above controls throughout the 30-day experiments. In the camostate group pancreatic ornithine decarboxylase activity was elevated after 2 h, reaching a maximum after 6 h (1,858.5 pmol 14CO2/h/mg DNA, about 200-fold above controls) followed by a significant increase in putrescine after 4 h and spermidine after 24 h while spermine remained unchanged. The trophic parameters increased in the following time sequence: thymidine kinase (12 h), DNA polymerase (12 h), protein (24 h), pancreatic weight (24 h) and DNA (5 days). alpha-Difluoromethylornithine significantly delayed and reduced the camostate-induced increase in ornithine decarboxylase activity and polyamine concentrations as well as the trophic parameters. Application of the CCK receptor antagonist L-364,718 resulted in complete inhibition of the increases in ornithine decarboxylase, polyamines and all trophic parameters. These data indicate an important role for ornithine decarboxylase and polyamines in camostate-induced pancreatic growth and hormonal mediated pancreatic adaptation in rats.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509268     DOI: 10.1159/000199867

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

1.  Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development.

Authors:  C Löser; A Eisel; D Harms; U R Fölsch
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

2.  Activation of polyamine catabolism in transgenic rats induces acute pancreatitis.

Authors:  L Alhonen; J J Parkkinen; T Keinanen; R Sinervirta; K H Herzig; J Jänne
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

3.  Stimulation of pancreatic growth. Distal small bowel resection mediated by increased levels of cholecystokinin.

Authors:  K Yoshinaga; J Ishizuka; G Gomez; M Izukura; C M Townsend; Y Mishima; J C Thompson
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

4.  activated polyamine catabolism in acute pancreatitis: alpha-methylated polyamine analogues prevent trypsinogen activation and pancreatitis-associated mortality.

Authors:  Mervi T Hyvönen; Karl-Heinz Herzig; Riitta Sinervirta; Elke Albrecht; Isto Nordback; Juhani Sand; Tuomo A Keinänen; Jouko Vepsäläinen; Nikolay Grigorenko; Alex R Khomutov; Burkhard Krüger; Juhani Jänne; Leena Alhonen
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

5.  Uptake of extracellular, dietary putrescine is an important regulatory mechanism of intracellular polyamine metabolism during camostate-induced pancreatic growth in rats.

Authors:  C Löser; L Torff; U R Fölsch
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

6.  Expression of ornithine decarboxylase in pancreatic development.

Authors:  P C Lee
Journal:  Mol Cell Biochem       Date:  1995-10-04       Impact factor: 3.396

7.  Effect of neurotensin on pancreatic growth and pancreatic polyamine metabolism in rats.

Authors:  C Löser; R Nustede; H J Becker; H Köhler; U R Fölsch
Journal:  Int J Pancreatol       Date:  1995-10

8.  Investigation of Polyamine Metabolism and Homeostasis in Pancreatic Cancers.

Authors:  Chelsea Massaro; Jenna Thomas; Otto Phanstiel Iv
Journal:  Med Sci (Basel)       Date:  2017-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.